Select a calendar:
Filter October Events by Event Type:
Events for October 08, 2019
-
Interviews Open Forum
Tue, Oct 08, 2019 @ 01:00 PM - 02:00 PM
Viterbi School of Engineering Career Connections
Workshops & Infosessions
Increase your preparedness for interviews by attending this professional development Q&A moderated by Viterbi Career Connections staff or Viterbi employer partners.
For more information about Labs & Open Forums, please visit viterbicareers.usc.edu/workshops.
Location: Hughes Aircraft Electrical Engineering Center (EEB) - 132
Audiences: Everyone Is Invited
Contact: RTH 218 Viterbi Career Connections
-
ISE 651 - Epstein Seminar
Tue, Oct 08, 2019 @ 03:30 PM - 04:50 PM
Daniel J. Epstein Department of Industrial and Systems Engineering
Conferences, Lectures, & Seminars
Speaker: Dr. Dmitrii Ostrovskii, Postdoctoral Scholar
Talk Title: On Fast Rates In Empirical Risk Minimization Beyond Least-Squares
Host: Dr. Meisam Razaviyayn
More Information: October 8, 2019.pdf
Location: Ethel Percy Andrus Gerontology Center (GER) - 206
Audiences: Everyone Is Invited
Contact: Grace Owh
-
Mork Family Department of Chemical Engineering and Materials Science Seminar - Distinguished Lecture Series
Tue, Oct 08, 2019 @ 04:00 PM - 05:20 PM
Mork Family Department of Chemical Engineering and Materials Science
Conferences, Lectures, & Seminars
Speaker: Professor Yvonne Chen, University of California, Los Angeles
Talk Title: Engineering Next-Generation T Cells for Cancer Immunotherapy
Abstract: The adoptive transfer of T cells expressing chimeric antigen receptors (CARs) has demonstrated clinical efficacy in the treatment of advanced cancers, with anti-CD19 CAR-T cells achieving up to 90% complete remission among patients with relapsed B-cell malignancies. However, challenges such as antigen escape and immunosuppression limit the long-term efficacy of adoptive T-cell therapy. Here, I will discuss the development of next-generation T cells that can target multiple cancer antigens and resist immunosuppression, thereby increasing the robustness of therapeutic T cells against tumor defense mechanisms. Specifically, I will discuss the development of multi-input receptors and T cells that can interrogate intracellular antigens. I will also discuss the engineering of T cells that can effectively convert TGF-beta from a potent immunosuppressive cytokine into a T-cell stimulant. This presentation will highlight the potential of synthetic biology in generating novel mammalian cell systems with multifunctional outputs for therapeutic applications.
Host: WIChE
Location: John Stauffer Science Lecture Hall (SLH) - 102
Audiences: Everyone Is Invited
Contact: Karen Woo/Mork Family
